Million-dollar investment leads AGC Biologics to start new staff hunt – needs up to 300 new employees
Due to increased demand, AGC Biologics invest DKK 1.2bn in a new Danish factory. The contract manufacturer expects that the expanded production capacity will bring about a significant expansion of the staff group.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
Due to an increase in demands, AGC Biologics now chooses to establish a new factory at around DKK 1.2bn (USD 195.2m), which more than doubles the firm's Danish production capacity, according to AGC Biologics' Vice President, Technical Operations, Christian Christensen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Danish Covid-19 vaccine might be ready before 2021
For subscribers
.jpg&w=384&q=75)
